Clinical trials: Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
- Condition Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
- Funder type Industry (pharma, biotech, devices)
We couldn't retrieve this information right now
The trial registry didn't respond. This is usually temporary — please try again in a moment.